Moreover, SLC25A40 has been implicated in ovarian and breast cancer35,36, and cancer resistance in human leukemia K562 cells37, suggesting that transporter-specific control of mtGSH may have broader implications for inflammatory and mitochondrial diseases. Here, SLC25A40 is linked to cancer.